Pnc Financial Services »

Keros Therapeutics shares owned by Pnc Financial Services

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Pnc Financial Services from 13F filings

Historical chart of Pnc Financial Services investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Pnc Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Pnc Financial Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $874 22 39.77

More positions owned by Pnc Financial Services

Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Et (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Erie Indty Cl A (ERIE)
V.F. Corporation (VFC)
Ishares Tr Msci Usa Qlt F (QUAL)
Wisdomtree Tr Us Qtly Div Gr (DGRW)
Procter & Gamble Company (PG)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Home Depot (HD)
Ishares Tr Msci Intl Qual (IQLT)

View all positions for Pnc Financial Services

Top funds holding Keros Therapeutics

Vanguard Group
OrbiMed Advisors
Braidwell
Darwin Global Management
T. Rowe Price Associates
Candriam Luxembourg S.C.A.
Citadel Advisors
Franklin Resources
ADAR1 Capital Management
Eventide Asset Management
Millennium Management
Deutsche Bank Aktiengesellschaft
Opaleye Management
Blue Owl Capital Holdings
Nantahala Capital Management

View all funds holding Keros Therapeutics